Fresenius Kabi
Telmo Neves is a seasoned professional in the pharmaceutical industry, currently serving as Senior Vice President of Regulatory Affairs, Quality & Market Access at Fresenius Kabi since September 2010. Neves has held multiple leadership roles within the company, including Vice President of Regulatory Affairs & Project Management and Director of Regulatory Affairs & Project Management for Europe, Latin America, Middle East, and Africa. Prior to joining Fresenius Kabi, Neves gained experience as a Pharmacist at Farmácia Barros and completed various internships in community pharmacy and clinical analysis. Academic credentials include a Master's in Drug Technology and Pharmaceutical Sciences from Universidade de Coimbra, alongside executive education in Strategy Execution and Project Management.
This person is not in any teams
This person is not in any offices
Fresenius Kabi
16 followers
Fresenius Kabi is a global healthcare company that specializes in lifesaving medicines and technologies for infusion, transfusion and clinical nutrition. Our products and services are used to help care for critically and chronically ill patients. Fresenius Kabi’s product portfolio comprises a comprehensive range of I.V. generic drugs, infusion therapies and clinical nutrition products as well as the devices for administering these products. In the field of biosimilars, Fresenius Kabi focuses on autoimmune diseases and oncology. In 2019, the first biosimilar product by Fresenius Kabi was launched. Within transfusion medicine and cell therapies, Fresenius Kabi offers products for collection of blood components and extracorporeal therapies.